This is a randomized prospective outcomes study comparing two groups of patients. One group
will receive liposomal bupivacaine plus bupivacaine and the other will receive bupivacaine
alone in interscalene blocks when undergoing total shoulder arthroplasty. The purpose of the
study is to determine if LB plus bupivacaine provides superior pain control compared to
bupivacaine alone when injected in an interscalene block for patients undergoing total
shoulder arthroplasty surgery.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute